| __timestamp | Amphastar Pharmaceuticals, Inc. | Viatris Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 28427000 | 581800000 |
| Thursday, January 1, 2015 | 37065000 | 671900000 |
| Friday, January 1, 2016 | 41199000 | 876700000 |
| Sunday, January 1, 2017 | 43415000 | 857900000 |
| Monday, January 1, 2018 | 57564000 | 822200000 |
| Tuesday, January 1, 2019 | 68853000 | 778200000 |
| Wednesday, January 1, 2020 | 67229000 | 512600000 |
| Friday, January 1, 2021 | 60932000 | 681000000 |
| Saturday, January 1, 2022 | 74771000 | 662200000 |
| Sunday, January 1, 2023 | 73741000 | 910700000 |
Igniting the spark of knowledge
In the competitive landscape of pharmaceuticals, innovation is key. Over the past decade, Viatris Inc. and Amphastar Pharmaceuticals, Inc. have shown distinct strategies in their research and development (R&D) investments. From 2014 to 2023, Viatris consistently outpaced Amphastar, investing nearly 10 times more in R&D annually. In 2023, Viatris allocated approximately $910 million, a 56% increase from 2020, while Amphastar's investment grew by 160% over the same period, reaching around $74 million. This disparity highlights Viatris's aggressive push towards innovation, potentially positioning it as a leader in pharmaceutical advancements. Meanwhile, Amphastar's steady growth in R&D spending reflects a more cautious, yet promising, approach. As both companies continue to evolve, their investment strategies will likely shape their future roles in the industry.
Comparing Innovation Spending: Gilead Sciences, Inc. and Viatris Inc.
R&D Insights: How Vertex Pharmaceuticals Incorporated and Viatris Inc. Allocate Funds
Research and Development Investment: Takeda Pharmaceutical Company Limited vs Viatris Inc.
Comparing Innovation Spending: Incyte Corporation and Amphastar Pharmaceuticals, Inc.
Research and Development Expenses Breakdown: Viatris Inc. vs Insmed Incorporated
Viatris Inc. or ImmunityBio, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Viatris Inc. and HUTCHMED (China) Limited
Viatris Inc. or MannKind Corporation: Who Invests More in Innovation?
Analyzing R&D Budgets: Opthea Limited vs Amphastar Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Bausch Health Companies Inc. and Amphastar Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc. or MannKind Corporation: Who Invests More in Innovation?
R&D Insights: How Amphastar Pharmaceuticals, Inc. and Viridian Therapeutics, Inc. Allocate Funds